The pharmaceutical sector has taken center stage since late 2019 when the globe was caught off guard by the COVID-19 epidemic. Manufacturers are finding it difficult to adapt their production volumes, marketing strategies, and supply chains. A related issue is the emergence of new variations, which further complicates the situation. The pharmaceutical sector was designated as a “trillion-dollar industry” in 2014, implying that the largest corporations are enjoying a sizable slice of the pie. Despite the fact that, as of February 2021, this sector had lagged the market by around 3 percentage points. Moderna, Inc. has grown to become one of the most valuable pharmaceutical and biotech firms in the world. The company plans to generate 2.5 billion vaccine doses by 2021. It has already agreed to give more than a billion doses to people all across the world. Firms like Pfizer Inc. and Johnson & Johnson, which have already dominated the world’s top pharmaceutical businesses, are rushing to raise output following the results of Phase 3 clinical studies. India has become the next hub of the pandemic’s second wave. It is the world’s largest supplier of generic pharmaceuticals. India’s pharmaceutical products have been exported to more than 200 countries. India’s pharmaceutical sector is expected to be valued at $65 billion by 2024. India produces more than 500 active pharmaceutical ingredients and is the source of 60,000 generic brands. OTC drugs, which are used to treat general and non-life-threatening diseases, make up the bulk of the supply. Mumbai, Bangalore, Hyderabad, Pune, Visakhapatnam, and Ahmedabad are all major pharmaceutical hubs. India is home to some of the world’s most well-known pharmaceutical companies. In 2001, Novartis established a presence in Hyderabad, India. The office provides support to the pharmaceuticals, eye care, and generic medications areas of the corporation. India has the ability to take its pharmaceutical industry to new heights. Key factors include a large workforce, inventive scientific manpower, inexpensive R&D costs, and low-cost production. Following the onset of the COVID-19 pandemic, the pharmaceutical industry, as well as mutual funds that invest in it, have performed better.
Here is Insider Monkey’s list of the top 15 pharmaceutical companies in India. Abbott India Ltd is one of India’s most admired, largest, and oldest pharmaceutical enterprises. It employs approximately 2,600 employees and serves customers through a network of 35 distribution sites. Ipca Laboratories Limited, situated in Mumbai, India, is a multinational pharmaceutical firm. It has about 350 product compositions in its portfolio. The company is ranked 14th among India’s leading pharmaceutical companies. Dr. Murali K. Div started Divi Laboratories in 1990. It offers 120 products in its portfolio that cover a wide range of therapeutic areas. The company is ranked 13th among India’s leading pharmaceutical companies. Biocon is one of India’s most well-known biopharmaceutical firms. It provides services in more than 120 countries by identifying new and cost-effective solutions. The Torrent Group’s flagship firm is Torrent Pharmaceuticals Ltd. As the global consumption of well-known companies like Moderna, Inc. pharmaceuticals rises, the company is seeing increasing demand. It manufactures drugs for a wide range of medical conditions, including diabetes and cardiovascular disease. Alkem Laboratories specializes in the development and marketing of high-quality branded generics. At the moment, the corporation operates through a total of 21 manufacturing locations. For more companies on this list, click Top Pharmaceutical Companies in India.
